HEAL Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
MINUTES OF PROCEEDINGS
Meeting No. 42
THURSDAY, May 14, 1998
The Standing Committee on Health met in a televised session at 9:29 o’clock a.m., this day, in Room 253-D, Centre Block, the Chair, Beth Phinney, presiding.
Members of the Committee present: Carolyn Bennett, Elinor Caplan, Aileen Carroll, Maurice Dumas, Reed Elley, Lynn Myers, Maurice Vellacott, Joseph Volpe, Judy Wasylycia-Leis.
Acting Members present: John O’Reilly for Claude Drouin, Roger Gallaway for Dan McTeague, Gar Knutson for Rose-Marie Ur, Keith Martin for Grant Hill.
In attendance: From the Research Branch of the Library of Parliament: Odette Madore, Nancy Miller-Chenier and Gérald Lafrenière, Research Officers.
Pursuant to Standing Order 108(2), the Committee resumed consideration of natural health products. (See Minutes of Proceedings dated Thursday, November 20, 1997.)
Witnesses: From the Department of Health (United Kingdom):Richard Woodfield, Group Manager, Medicines Control Agency. From the Chemicals and Non-Prescription Drug Branch (Australia): Laurayne Bowler, Acting Director. From the Federal Institute for Drugs and Medical Devices via videoconference from Germany: Dr. Konstantin Keller, Director. From Health Canada (Health Protection Branch): Dann Michols, Director General, Therapeutic Products Programme. From Health Canada (Food Directorate): Ron Burke, Acting Director, Bureau of Food Regulatory, Interagency and Intergovernmental Affairs; Dr. Margaret Cheney, Chief, Nutrition Evaluation Division; Harry Conacher, Acting Director, Bureau of Chemical Safety.
Richard Woodfield, Laurayne Bowler and Konstantin Keller made opening statements and with the other witnesses answered questions.
At 11:55 the sitting was suspended.
At 12:00 the sitting resumed.
By unanimous consent, it was agreed that Lynn Myers be allowed to move the following motion -- That the motion adopted by the Committee during its May 5th meeting, dealing with the language of motions presented in Committee, be rescinded.
Keith Martin moved, -- That the motion be amended by adding after the word "rescinded", the following:
"And that the Committee table a report in the House containing a description of the events surrounding the adoption of the said motion."
After debate, the question being put on the amendment, it was, by a show of hands, negatived: YEAS: 2; NAYS: 6;
The question being put on the main motion, it was, by a show of hands, agreed to: YEAS: 6; NAYS 2;
Keith Martin moved, -- That the Health Committee invite the Health Minister and Health Canada officials to appear before the Committee to respond to questions relating to M-222, and report on progress made in the area of organ transplantation since the unanimous adoption of M-222 in the House of Commons on October 9, 1997.
After debate, the question being put on the motion, it was agreed to.
It was agreed, -- That the proposed budget submission for the Committee’s natural health products study be adopted.
At 12:20 o’clock p.m., the Committee adjourned to the call of the Chair.
ROGER PRÉFONTAINE
Clerk of the Committee